CN112830872A - 一种2,3,4-三羟基苯甲醛的合成方法 - Google Patents
一种2,3,4-三羟基苯甲醛的合成方法 Download PDFInfo
- Publication number
- CN112830872A CN112830872A CN201911163271.8A CN201911163271A CN112830872A CN 112830872 A CN112830872 A CN 112830872A CN 201911163271 A CN201911163271 A CN 201911163271A CN 112830872 A CN112830872 A CN 112830872A
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- trihydroxybenzaldehyde
- yield
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CRPNQSVBEWWHIJ-UHFFFAOYSA-N 2,3,4-trihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C(O)=C1O CRPNQSVBEWWHIJ-UHFFFAOYSA-N 0.000 title claims abstract description 10
- 238000001308 synthesis method Methods 0.000 title description 3
- 238000000034 method Methods 0.000 claims abstract description 29
- 230000022244 formylation Effects 0.000 claims abstract description 7
- 238000006170 formylation reaction Methods 0.000 claims abstract description 7
- 230000002194 synthesizing effect Effects 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229940126062 Compound A Drugs 0.000 claims description 7
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 4
- MJNJTZVLAVUIDU-UHFFFAOYSA-N dichloromethoxyethane Chemical compound CCOC(Cl)Cl MJNJTZVLAVUIDU-UHFFFAOYSA-N 0.000 claims description 4
- ROORDVPLFPIABK-UHFFFAOYSA-N diphenyl carbonate Chemical compound C=1C=CC=CC=1OC(=O)OC1=CC=CC=C1 ROORDVPLFPIABK-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- PWRBCZZQRRPXAB-UHFFFAOYSA-N 3-chloropyridine Chemical compound ClC1=CC=CN=C1 PWRBCZZQRRPXAB-UHFFFAOYSA-N 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 abstract description 16
- 239000002994 raw material Substances 0.000 abstract description 9
- 229940079877 pyrogallol Drugs 0.000 abstract description 8
- 238000010511 deprotection reaction Methods 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 239000012044 organic layer Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- BNQDCRGUHNALGH-UHFFFAOYSA-N benserazide Chemical compound OCC(N)C(=O)NNCC1=CC=C(O)C(O)=C1O BNQDCRGUHNALGH-UHFFFAOYSA-N 0.000 description 2
- 229960000911 benserazide Drugs 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 229940081615 DOPA decarboxylase inhibitor Drugs 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- 238000009619 Gattermann reaction Methods 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 238000007013 Reimer-Tiemann formylation reaction Methods 0.000 description 1
- 238000005874 Vilsmeier-Haack formylation reaction Methods 0.000 description 1
- 229940035678 anti-parkinson drug Drugs 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000534 dopa decarboxylase inhibitor Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供一种2,3,4‑三羟基苯甲醛的合成方法,所述2,3,4‑三羟基苯甲醛的合成是以邻苯三酚为起始原料,经过保护酚羟基、甲酰化、脱保护三个步骤。本发明原料廉价易得,操作简单,产品收率和纯度高,三废量少,所述方法具有优异的经济和环保效益。
Description
技术领域:
本发明涉及药物化学领域,具体来说,涉及一种2,3,4-三羟基苯甲醛的新的合成方法。
背景技术:
2,3,4-三羟基苯甲醛为抗帕金森药物苄丝肼的重要中间体,苄丝肼为外周多巴脱羧酶抑制剂,通常以苄丝肼:L-多巴为1:4的比例配制成复方制剂使用,治疗帕金森症效果显著。
关于2,3,4-三羟基苯甲醛的合成,目前方法众多,但所有文献或专利均以邻苯三酚(又名沒食子酚)为起始原料直接以以下面几种方法来合成:
方法一、以邻苯三酚与氢氰酸或氰化盐为原料发生Gattermann反应生成2,3,4-三羟基苯甲醛,例如氢氰酸(Chemische Berichte;vol.31;(1898);p.1768)、氰化锌(CN200410052772.6)等,此方法成本低,但由于产生的氰化氢剧毒,生产操作风险大,所以现在几乎已经弃用。
方法二、以邻苯三酚为原料与DMF及三氯氧磷发生Vilsmeier-Haack反应生成2,3,4-三羟基苯甲醛(参考Tetrahedron:Asymmetry;2000;11;3375-3393),此方法实际生产中直接以邻苯三酚为底物发生反应时,收率较低,且副反应非常多,后期分离难度较大。
方法三、以邻苯三酚为原料与三氯甲烷在氢氧化钠水溶液中发生Reimer-Tiemann反应(参考Journal of the American Chemical Society;vol.105;nb.7;(1983);p.2018-2021),此方法通常收率较低,在50%以下,且邻、对位比例相当。难以分离。
方法四、以邻苯三酚为原料直接与原甲酸三乙酯发生Friedel-Crafts反应(Justus Liebigs Annalen der Chemie;vol.763;(1972);p.109-120),此方法相对于其他几种方法反应过程较纯净,但因其含三个酚羟基,在后处理过程中,水及有机溶剂中溶解性都非常好,而且颜色较深,所以污水量太大,约为邻苯三酚投料量的40~50倍。这样极不利于工业化生产。
发明内容
本发明的目的在于克服现有技术中的不足,提供一条收率高、绿色环保的一种2,3,4-三羟基苯甲醛的制备方法,具体合成路线如下:
其合成方案,优选步骤如下:(第一步原料倍数为相对于化合物A,第二步原料倍数为相对于化合物B,第三步原料倍数为相对于化合物C)
第一步:反应瓶中加入化合物A、0.05倍三乙胺、1.1倍碳酸二苯酯、5倍甲基叔丁基醚(以上倍数均以邻苯三酚为基准的摩尔比),加热回流反应6~8小时,然后冷至室温(20~30℃),,有机层用5%NaOH洗涤3次,水洗1次,饱和氯化钠水溶液洗1次,浓缩除去70%的溶剂,搅拌下降温至-5℃析晶,抽滤干燥,即得化合物B.此步收率平行试验分布在95~97%。此步反应中,甲基叔丁基醚可重复使用;氢氧化钠水溶液可补加氢氧化钠后再利用;饱和氯化钠水溶液可补加氯化钠后再利用。
第二步:反应瓶中加入3倍甲基叔丁基醚冷至0~5℃,分批加入1倍三氯化铝,控温0~5℃之间,滴加1倍二氯甲基乙基醚,控温0~5℃之间,滴加化合物B的1倍甲基叔丁基醚溶液,控温0~5℃之间,反应2~3小时,缓慢的加入3倍水(以上倍数均以化合物B为基准的摩尔比),控温10℃以下,分层,有机层用5%氢氧化钠水溶液洗涤2次,饱和氯化钠水溶液洗1次,40℃减压蒸馏浓缩有机层至剩余约30%体积,搅拌下,冷至室温,然后冷冻至-5℃,搅拌2小时,抽滤,干燥。即得化合物C,此步收率平行试验分布在89~93%。此步反应中,甲基叔丁基醚可重复使用;反应完加水猝灭反应后,分出的水层,可调节PH为中性后重复使用3~4次;氢氧化钠水溶液可补加氢氧化钠后再利用;饱和氯化钠水溶液可补加氯化钠后再利用。
第三步:反应瓶中加入化合物C、3倍水(以上倍数均以化合物C为基准的摩尔比),加热回流1~1.5小时,搅拌下冷至5~10℃,抽滤干燥,即得化合物D,此步收率平行试验分布在93~95%。
以上三步反应的总收率在82~86%。
本发明与现有技术相比,其优势在于:
1.相对于直接甲酰化,虽然多了上保护和脱保护的反应步骤,但使用的原料便宜易得,分离简便,操作简单,污水量大幅减少,收率有所提高,便于工业化生产;
2.相对于直接甲酰化的各种方法,本路线可经过上述操作后,使所得产品(化合物D)含量直接达到99%以上;而直接甲酰化因为副反应较多,须经过多次纯化才能达到98%以上的含量,且每纯化一次,收率要损失10~20%,这就导致直接甲酰化方法后处理经多次纯化后,产品收率普遍偏低。
附图说明
图1为化合物B的HPLC检测谱图。
图2为化合物C的HPLC检测谱图。
图3为化合物D(目标产物)的HPLC检测谱图。
图4为反应路线图,同时为摘要附图。
具体实施方式
为了使本发明的技术手段、创作特征、工作流程、使用方法达成目的与功效易于明白了解,下面进一步阐述本发明。
化合物B的合成:
反应瓶中加入126克(1mol)化合物A、5.05克(0.05mol)三乙胺、235.4克(1.1mol)碳酸二苯酯、630ml甲基叔丁基醚,加热回流反应6~8小时,然后冷至室温(20~30℃),有机层用200ml5%NaOH洗涤3次,200ml水洗1次,200ml饱和氯化钠水溶液洗1次,浓缩除去70%的溶剂,搅拌下降温至-5℃析晶,抽滤干燥,即得146.4克化合物B,收率96.3%.
化合物B的HPLC检测结果参见图1。
化合物C的合成:
反应瓶中加入450ml甲基叔丁基醚冷至0~5℃,加入133.5克(1mol)三氯化铝,控温0~5℃之间,滴加129克(1mol)二氯甲基乙基醚,控温0~5℃之间,滴加含152克化合物B的304ml甲基叔丁基醚溶液,控温0~5℃之间,反应2~3小时,缓慢的加入400ml水,控温10℃以下,分层,有机层用200ml 5%氢氧化钠水溶液洗涤2次,200ml饱和氯化钠水溶液洗1次,40~50℃减压蒸馏浓缩有机层除去70%溶剂,搅拌下,冷至室温,然后冷冻至-5~0℃,搅拌2~3小时,抽滤,干燥。即得167.0克化合物C,收率92.8%
化合物C的HPLC检测结果参见图2。
化合物D的合成:
反应瓶中加入180克(1mol)化合物C、540ml水,加热回流1~1.5小时,搅拌下冷至5~10℃,抽滤干燥,即得145.7克化合物D,收率94.6%。
化合物D的HPLC检测结果参见图3。
核磁数据:
(CDCl3,300MHz):9.83(s,1H);7.68(d,J=9.0Hz,1H);6.84(d,J=9.0Hz,1H).
以上显示和描述了本发明的基本原理和主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (7)
2.根据权利要求1所述的路线,其特征在于,所述步骤1包括:将化合物A、三乙胺、碳酸二苯酯在溶剂中反应,得到化合物B。
3.根据权利要求1所述的方法,其特征在于,所述步骤2包括:将三氯化铝溶于溶剂中,然后依次滴加二氯甲基乙基醚、化合物B的溶液,反应即得化合物C。
4.根据权利要求1所述的方法,其特征在于,所述步骤3包括:化合物C在水中加热回流,即得化合物D。
5.根据权利要求2所述的方法,其特征在于,所述步骤1的反应温度为50~60℃,所述步骤2的反应温度为0~5℃。
6.根据权利要求2所述的方法,其特征在于,所述步骤1中化合物A、三乙胺、碳酸二苯酯的摩尔比为1:(0.01~0.05):(1.0~1.3)。
7.根据权利要求3所述的方法,其特征在于,所述步骤2中化合物B、三氯化铝、二氯甲基乙基醚的摩尔比为1:(1~1.2):(1~1.2)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911163271.8A CN112830872A (zh) | 2019-11-25 | 2019-11-25 | 一种2,3,4-三羟基苯甲醛的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911163271.8A CN112830872A (zh) | 2019-11-25 | 2019-11-25 | 一种2,3,4-三羟基苯甲醛的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112830872A true CN112830872A (zh) | 2021-05-25 |
Family
ID=75922021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911163271.8A Pending CN112830872A (zh) | 2019-11-25 | 2019-11-25 | 一种2,3,4-三羟基苯甲醛的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112830872A (zh) |
-
2019
- 2019-11-25 CN CN201911163271.8A patent/CN112830872A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2397459B1 (en) | Method for producing phenylacetamide compound | |
US8680329B2 (en) | Process for preparation of α-ketoglutaric acid | |
CN109232178B (zh) | 制备高纯度羟基酪醇的新方法 | |
CN111689878A (zh) | 一种三氟甲磺酸酐制备工艺 | |
WO2024119744A1 (zh) | 亚磷酸酯类抗氧剂双(2,6-二叔丁基-4-甲基苯基)季戊四醇二亚磷酸酯的合成方法 | |
US8754256B2 (en) | Process for preparation of L-Arginine α-ketoglutarate 1:1 and 2:1 | |
CN101735085B (zh) | 动力学拆分制备d-丝氨酸的方法 | |
CN111285782B (zh) | 一种1-氰基环己基乙腈的制备方法 | |
CN112830872A (zh) | 一种2,3,4-三羟基苯甲醛的合成方法 | |
EP3853195B1 (en) | Process to recover high quality 3-methyl-but-3-en-1-ol | |
CN106588843B (zh) | 一种脱氢乙酸钠/脱氢醋酸连续生产方法 | |
CN111116339A (zh) | 人工合成姜黄素及其衍生物的方法 | |
CN117800824A (zh) | 一种2,3,4-三羟基苯甲醛的新的合成方法 | |
CN107118128B (zh) | 3,4-二羟基苯甲腈的制备方法 | |
CN110330422B (zh) | 一种2,6-二乙基-4-甲基苯乙酸的制备方法 | |
JP4775936B2 (ja) | 光学活性マンデル酸類の製造方法 | |
CN101607914A (zh) | 对叔丁基苄胺的简易制备方法 | |
CN103130626B (zh) | 一种3-叔丁基-2,5-二羟基-苯甲醛的制备方法 | |
CN115677546B (zh) | 一种d-对甲砜基苯丝氨酸乙酯的手性合成方法 | |
RU2286335C2 (ru) | Способ получения аминоуксусной кислоты | |
RU2331630C1 (ru) | Способ получения 1,1,3-тригидроперфторпропиловых эфиров эпсилон-аминокапроновой кислоты | |
CN109516899B (zh) | 一种高纯度白藜芦醇的制备方法 | |
CN112939920B (zh) | 一种龙血竭红素a或龙血竭红素b的制备方法 | |
JP5561564B2 (ja) | マンデル酸類の製造方法およびマンデル酸類結晶 | |
RU2331634C1 (ru) | Способ получения 3-феноксифенилциангидрина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210525 |